Ovid Therapeutics Inc.
OVID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,625 | $23,459 | $22,159 | $66,302 |
| - Cash | $20,611 | $28,415 | $21,136 | $26,301 |
| + Debt | $1,409 | $14,099 | $14,430 | $14,755 |
| Enterprise Value | -$17,577 | $9,143 | $15,453 | $54,756 |
| Revenue | $132 | $6,272 | $130 | $76 |
| % Growth | -97.9% | 4,724.6% | 71.1% | – |
| Gross Profit | $115 | $6,272 | $130 | $76 |
| % Margin | 87.1% | 100% | 100% | 100% |
| EBITDA | -$12,141 | -$4,974 | -$12,409 | -$10,762 |
| % Margin | -9,197.7% | -79.3% | -9,545.4% | -14,160.5% |
| Net Income | -$12,158 | -$4,684 | -$10,235 | -$9,253 |
| % Margin | -9,210.6% | -74.7% | -7,873.1% | -12,175% |
| EPS Diluted | -0.17 | -0.066 | -0.14 | -0.13 |
| % Growth | -158% | 52.9% | -7.7% | – |
| Operating Cash Flow | -$12,872 | -$4,774 | -$10,280 | -$10,008 |
| Capital Expenditures | $0 | $0 | $0 | -$22 |
| Free Cash Flow | -$12,872 | -$4,774 | -$10,280 | -$10,030 |